Neutrophil Chemotactic Activity in Bronchoalveolar Lavage Fluid of Patients with AIDS-associated Pneumocystis carinii Pneumonia

References

• Murray J F, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Am Rev Respir Dis 1990; 141: 1582–98
   PubMed Web of Science ®Google Scholar
• Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 1992; 327: 1853–60
   PubMed Web of Science ®Google Scholar
• Limper A H, Offord K P, Smith T F, Martin W J, II. Pneumocystis carinii pneumonia: Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140: 1204–9
   PubMed Web of Science ®Google Scholar
• Bentsen K D, Nielsen T L, Eeftinck Schattenkerk J KM, Jensen B N, Lundgren J D. Serum type III procollagen peptide in patients with Pneumocystis carinii infection. Am Rev Respir Dis 1993; 148: 1558–62
   PubMed Web of Science ®Google Scholar
• Benfield T L, Dichter J, van Steenwijk R, Junge J, Lipschik G, Nielsen T L. Interleukin-8 and eicosanoid production in the lungs from patients with Pneumocystis carinii pneumonia and AIDS. Resp Med 1995; 89: 285–90
   PubMed Web of Science ®Google Scholar
• Bozette S A, Morton S C. Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia. J Acquir Immune Defic Syndr 1995; 8: 345–7
   Web of Science ®Google Scholar
• Benfield T L, Prentø P, Junge J, Vestbo J, Lundgren J D. Alveolar damage in AIDS-associated Pneumocystis carinii pneumonia. Chest 1997; 111: 1193–7
   PubMed Web of Science ®Google Scholar
• Travis W D, Pittaluga S, Lipschik G Y, Ognibene F P, Suffredini A F, Masur H. A typical pathologic manifestation of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Am J Surg Pathol 1990; 14: 615–25
   PubMed Web of Science ®Google Scholar
• Weber W R, Askin F B, Dehner L P. Lung biopsy in Pneumocystis carinii pneumonia. Am J Clin Pathol 1977; 67: 11–19
   PubMed Web of Science ®Google Scholar
• Mason G R, Hashimoto C H, Dickman P S, Foutty L F, Cobb C J. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989; 139: 1336–42
   PubMed Web of Science ®Google Scholar
• Smith R L, el Sadr W M, Lewis M L. Correlation of bron-choalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 1988; 93: 60–3
   PubMed Web of Science ®Google Scholar
• Vestbo J, Nielsen T L, Junge J, Lundgren J D. Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P. carinii pneumonia Chest 1993; 104: 109–13
   Google Scholar
• Weiss S. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–76
   PubMed Web of Science ®Google Scholar
• Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547–59
   PubMed Web of Science ®Google Scholar
• Larsen C G, Anderson A O, Appela E, Oppenheim J J, Matsu-Shima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464–6
   PubMed Web of Science ®Google Scholar
• Leonard E J, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D. Leucocyte specificity and binding of human neu-trophil attractant activating protein-l. J Immun 1990; 1323–30
   PubMed Web of Science ®Google Scholar
• Lipschik G Y, Doerfler M E, Kovacs J A, Travis W D, Andrawis V A, Lawrence M G. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 1993; 104: 763–9
   PubMed Web of Science ®Google Scholar
• Benfield T L, Vestbo J, Junge J, Nielsen T L, Jensen A MB, Lundgren J D. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Resp Crit Care Med 1995; 151: 1058–62
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Lab Invest 1968; 21: 77
   PubMed Web of Science ®Google Scholar
• Kharazmi A, Høiby N, Valerius N H. Effect of antimalarial drugs on human neutrophil chemotaxis in vitro. Acta Pathol Microbiol Immun Scand 1983; 91C: 293
   Google Scholar
• Jensen P, Kharazmi A. Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro. J Immun Methods 1991; 144: 43–8
   PubMed Web of Science ®Google Scholar
• Ko Y, Mukaida N, Panyutich A, Voitenk N N, Matsushima K, Kawai T, Kasahara T. A sensitive enzyme-linked immuno-sorbent assay for human interleukin-8. J Immun Meth 1991; 149: 227–35
   Web of Science ®Google Scholar
• White M W, Igarashi Y, Lundgren J D, Shelhamer J H, Kaliner M. Hydrocortisone inhibits RBL mediator release induced by neutrophil derived histamine releasing activity as well as by anti-IgE. J Immun 1991; 147: 667–73
   PubMed Web of Science ®Google Scholar
• Martin T R, Altman L C, Albert R K, Henderson W R. Leu-kotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106–11
   PubMed Web of Science ®Google Scholar
• McCain R W, Holden E P, Blackwell C P, Christman J W. Leu-kotriene B4 stimulates human polymorphnuclear leucocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol 1994; 10: 651–7
   PubMed Web of Science ®Google Scholar
• Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 1990; 171: 1797–802
   PubMed Web of Science ®Google Scholar
• Walz A, Burgener R, Car B D, Baggiolini M, Kunkel S L, Strieter R M. Strucure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 1991; 174: 1355–62
   PubMed Web of Science ®Google Scholar
• Kurdowska A, Miller E J, Noble J M, Baughman R P, Matthay M A, Brelsford W G, Cohen A B. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immun 1996; 157: 2699–706
   PubMed Web of Science ®Google Scholar
• Goodman R B, Strieter R M, Martin D P, Steinberg K P, Milberg J A, Maunder R J. Inflammatory cytokines in patients with persistence of the acute respiratory dstress syndrome. Am J Respir Crit Care Med 1996; 154: 602–11
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel S L. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neu-trophils. J Clin Invest 1989; 84: 1045–9
   PubMed Web of Science ®Google Scholar
• Miller E J, Cohen A B, Nagao S, Griffith D, Maunder R J, Martin T J. Elevated levels of NAP-1 interleukin-8 are present in airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427
   PubMed Web of Science ®Google Scholar
• Richman-Eisenstat J BY, Jorens P G, Hébert C A, Ueki I, Nadel J A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264: L413–8
   PubMed Web of Science ®Google Scholar
• Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogure T. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145: 85–91
   PubMed Web of Science ®Google Scholar